한글목차

임질 치료제 시장은 2023-2028년간 5억 4,150만 달러 확대되고, 예측 기간 중 연평균 복합 성장률(CAGR)은 5.55%를 나타낼 것으로 예측됩니다.

임질 치료제 시장에 대한 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 게재했습니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공합니다. 임질 유병률 상승, 임질에 관련된 고리스크 합병증, 새로운 진단 검사 사용 증가에 의해 시장 성장이 촉진되고 있습니다.

본 조사에서는 향후 몇 년간 임질 치료제 시장 성장을 가속하는 주요인 중 하나로서 항생제 내성과 싸우기 위한 정부 이니셔티브 증가를 들고 있습니다. 또한 임질 예방 백신의 등장이나 신속한 파트너 요법 채택 확대도 시장의 큰 수요로 연결될 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제3장 시장 규모 평가

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2023년)
• 시장 전망2023-2028년)

제4장 시장 규모 실적

• 세계의 임질 치료제 시장(2018-2022년)
• 유통 채널별 부문 분석(2018-2022년)
• 치료별 부문 분석(2018-2022년)
• 지역별 부문 분석(2018-2022년)
• 국가별 부문 분석(2018-2022년)

제5장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제6장 시장 세분화 : 유통 채널별

• 시장 세분화
• 비교 : 유통 채널별
• 병원 약국 : 시장 규모와 예측(2023-2028년)
• 소매 약국 : 시장 규모와 예측(2023-2028년)
• 온라인 약국 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 유통 채널별

제7장 시장 세분화 : 치료법별

• 시장 세분화
• 치료법별 비교
• 단일요법 : 시장 규모와 예측(2023-2028년)
• 병용요법 : 시장 규모와 예측(2023-2028년)
• 시장 기회 세라피

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2023-2028년)
• 유럽 : 시장 규모와 예측(2023-2028년)
• 아시아 : 시장 규모와 예측(2023-2028년)
• 세계 기타 지역 : 시장 규모와 예측(2023-2028년)
• 미국 : 시장 규모와 예측(2023-2028년)
• 독일 : 시장 규모와 예측(2023-2028년)
• 중국 : 시장 규모와 예측(2023-2028년)
• 영국 : 시장 규모와 예측(2023-2028년)
• 일본 : 시장 규모와 예측(2023-2028년)
• 시장 기회 : 지역 상황별

제10장 성장 촉진요인, 과제, 기회, 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회 및 성장 억제요인

제11장 경쟁 구도

• 개요
• 경쟁 구도
• 혼란 상황
• 업계 리스크

제12장 경쟁 분석

• 기업 개요
• 기업의 시장 포지셔닝
• Apotex Inc.
• Aurobindo Pharma Ltd.
• Bristol Myers Squibb Co.
• Cipla Inc.
• Debiopharm International SA
• Entasis Therapeutics
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Hikma Pharmaceuticals Plc
• Lupin Ltd.
• Mayne Pharma Group Ltd.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Therapyx Inc.

제13장 부록

영문목차

The gonorrhea therapeutics market is forecasted to grow by USD 541.5 million during 2023-2028, accelerating at a CAGR of 5.55% during the forecast period. The report on the gonorrhea therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of gonorrhea, high-risk complications associated with gonorrhea, and growing use of new diagnostic tests.

Technavio's gonorrhea therapeutics market is segmented as below:

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Therapy

• Monotherapy
• Combination therapy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising government initiatives to combat antibiotic resistance as one of the prime reasons driving the gonorrhea therapeutics market growth during the next few years. Also, advent of vaccines for prevention of gonorrhea and increased adoption of expedited partner therapy will lead to sizable demand in the market.

The report on the gonorrhea therapeutics market covers the following areas:

• Gonorrhea therapeutics market sizing
• Gonorrhea therapeutics market forecast
• Gonorrhea therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gonorrhea therapeutics market vendors that include Apotex Inc., Aurobindo Pharma Ltd., Bristol Myers Squibb Co., Cipla Inc., Debiopharm International SA, Entasis Therapeutics, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Mayne Pharma Group Ltd., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Therapyx Inc.. Also, the gonorrhea therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Gonorrhea Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Gonorrhea Therapeutics Market 2018 - 2022 ($ million)
• 4.2 Distribution Channel segment analysis 2018 - 2022
  • Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.3 Therapy segment analysis 2018 - 2022
  • Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
  • Chart on Distribution Channel - Market share 2023-2028 (%)
  • Data Table on Distribution Channel - Market share 2023-2028 (%)
• 6.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 6.3 Hospital pharmacies - Market size and forecast 2023-2028
  • Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
  • Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
• 6.4 Retail pharmacies - Market size and forecast 2023-2028
  • Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
  • Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
• 6.5 Online pharmacies - Market size and forecast 2023-2028
  • Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
  • Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Therapy

• 7.1 Market segments
  • Chart on Therapy - Market share 2023-2028 (%)
  • Data Table on Therapy - Market share 2023-2028 (%)
• 7.2 Comparison by Therapy
  • Chart on Comparison by Therapy
  • Data Table on Comparison by Therapy
• 7.3 Monotherapy - Market size and forecast 2023-2028
  • Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
• 7.4 Combination therapy - Market size and forecast 2023-2028
  • Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Therapy
  • Market opportunity by Therapy ($ million)
  • Data Table on Market opportunity by Therapy ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Apotex Inc.
  • Apotex Inc. - Overview
  • Apotex Inc. - Product / Service
  • Apotex Inc. - Key news
  • Apotex Inc. - Key offerings
• 12.4 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
• 12.5 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
• 12.6 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
• 12.7 Debiopharm International SA
  • Debiopharm International SA - Overview
  • Debiopharm International SA - Product / Service
  • Debiopharm International SA - Key news
  • Debiopharm International SA - Key offerings
• 12.8 Entasis Therapeutics
  • Entasis Therapeutics - Overview
  • Entasis Therapeutics - Product / Service
  • Entasis Therapeutics - Key offerings
• 12.9 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 12.10 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.11 Hikma Pharmaceuticals Plc
  • Hikma Pharmaceuticals Plc - Overview
  • Hikma Pharmaceuticals Plc - Business segments
  • Hikma Pharmaceuticals Plc - Key news
  • Hikma Pharmaceuticals Plc - Key offerings
  • Hikma Pharmaceuticals Plc - Segment focus
• 12.12 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Product / Service
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
• 12.13 Mayne Pharma Group Ltd.
  • Mayne Pharma Group Ltd. - Overview
  • Mayne Pharma Group Ltd. - Business segments
  • Mayne Pharma Group Ltd. - Key news
  • Mayne Pharma Group Ltd. - Key offerings
  • Mayne Pharma Group Ltd. - Segment focus
• 12.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 12.15 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Therapyx Inc.
  • Therapyx Inc. - Overview
  • Therapyx Inc. - Product / Service
  • Therapyx Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
  • 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations